Biotech SF
San Francisco Bay Area biotech stories.
Friday, March 18, 2011
Affymax in $50 million stock sale
Affymax Inc. is planning to raise about $50 million in a sale of its common stock, the company said Friday.
Palo Alto-based Affymax (NASDAQ:AFFY) plans to sell about 8.5 million shares to the public at $5.90 per share.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment